White Papers

31. Oncolytic Virus Therapy: Global Clinical Trial Landscape (2024) 1/30/2025

    Addressing immunological challenges and navigating the evolving regulatory environment is critical for its successful integration into clinical practice.

32. Triple-Negative Breast Cancer: Global Clinical Trial Landscape 1/30/2025

    With over 1,500 TNBC-focused clinical trials since 2019, research efforts into Triple-negative breast cancer (TNBC) treatments are accelerating despite challenges such as drug resistance.

33. What Is Healthcare Data Interoperability And Why Does It Matter For Clinical Research? 1/28/2025

    Explore how healthcare data interoperability can transform patient outcomes, streamline clinical research, and enhance efficiencies while addressing key challenges and global initiatives.

34. Merits Of A Multifaceted Approach To Clinical Trial Recruitment 1/27/2025

    The best way to address clinical trial recruitment challenges is with a multifaceted approach that goes beyond traditional channels and ways of thinking.

35. Proving The Return On Investment For eRegulatory 1/22/2025

    A study of how leading research centers, CROs, and sponsors cover the cost of eRegulatory tools... and then some.

36. Fit-For-Purpose Biomarker Development 1/17/2025

    Here, we highlight the essential framework of a “fit-for-purpose” biomarker development strategy, emphasizing strategic and transactional engagements with clinical research organizations.

37. Biomarkers In Oncology Studies 1/17/2025

    Here we provide an overview of oncology biomarker development and strategic considerations.

38. Overcoming Issues Of Non-Enrolling Sites In Clinical Trials 1/14/2025

    Explore the challenges of non-enrolling sites in clinical trials, focusing on the benefits of leveraging artificial intelligence (AI) and machine learning (ML) in addressing those issues.

39. Epidermolysis Bullosa: Future Perspectives In Drug Development 1/14/2025

    Recent breakthroughs are signaling a promising shift in the landscape of Epidermolysis bullosa (EB) care from focusing on pain management to a growing commitment to curative strategies.

40. Gene Therapy In Neurology: The Case For Optimism 1/14/2025

    Advancements in genetic therapy are revolutionizing the treatment of neurological diseases, with promising results from preclinical studies leading to clinical trials focused on safety and efficacy.